Orchid Pharma Limited (NSE:ORCHPHARMA)

Market Cap	34.92B
Revenue (ttm)	8.21B
Net Income (ttm)	524.05M
Shares Out	50.72M
EPS (ttm)	10.33
PE Ratio	66.65
Forward PE	33.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,895
Average Volume	59,323
Open	714.40
Previous Close	705.10
Day's Range	675.00 - 714.40
52-Week Range	603.80 - 1,578.95
Beta	0.45
RSI	32.22
Earnings Date	Feb 9, 2026

About Orchid Pharma

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 736
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORCHPHARMA

Financial Performance

In 2024, Orchid Pharma's revenue was 9.22 billion, an increase of 12.52% compared to the previous year's 8.19 billion. Earnings were 996.57 million, an increase of 8.13%.